Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Erstellt von fchar99 

Insmed Inc. diskutieren

Insmed Inc.

WKN: A1JJA3 / Symbol: INSM / Name: Insmed / Aktie / Biotechnologie & medizinische Forschung / Small Cap /

68,50 €
-2,14 %

Einschätzung Buy
Rendite (%) 10,32 %
Kursziel 82,97
Veränderung
Endet am 08.07.25

Insmed Incorporated (NASDAQ: INSM) had its price target raised by analysts at HC Wainwright from $70.00 to $90.00. They now have a "buy" rating on the stock.
Ratings data for INSM provided by MarketBeat

Einschätzung Buy
Rendite (%) 6,92 %
Kursziel 87,84
Veränderung
Endet am 09.07.25

Insmed Incorporated (NASDAQ: INSM) had its price target raised by analysts at Guggenheim from $70.00 to $95.00. They now have a "buy" rating on the stock.
Ratings data for INSM provided by MarketBeat

Einschätzung Buy
Rendite (%) 2,96 %
Kursziel 94,20
Veränderung
Endet am 10.07.25

Insmed Incorporated (NASDAQ: INSM) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $74.00 to $102.00. They now have a "buy" rating on the stock.
Ratings data for INSM provided by MarketBeat

Einschätzung Buy
Rendite (%) -1,42 %
Kursziel 77,95
Veränderung
Endet am 12.07.25

Insmed Incorporated (NASDAQ: INSM) had its price target raised by analysts at Morgan Stanley from $60.00 to $85.00. They now have an "overweight" rating on the stock.
Ratings data for INSM provided by MarketBeat